The gendered impact of coronavirus disease (COVID-19): do estrogens play a role?
Giovanni GrandiFabio FacchinettiJohannes BitzerPublished in: The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception (2020)
Objective: Although sex-disaggregated data for COVID-19 show equal numbers of cases between men and women, there seem to be sex differences in mortality rate and vulnerability to the disease: more men than women are dying. Methods: We have explored the potential role of estrogens in this COVID-19 gendered impact. Results: Estrogens stimulate the humoral response to viral infections, while testosterone and progesterone give an immune suppression of both innate and cell-mediated immune responses. We hypothesise that estrogens, in particular estradiol but also synthetic estrogen such as ethinylestradiol, could protect women from the most serious complications of COVID-19. The use of medications that keep hormonal levels high and stable, such as combined hormonal contraceptive, could therefore play a protective role. These potential benefits overtake the thrombotic risk in healthy women. As stated by the World Health Organization, all modern methods of contraception were safe to use during the COVID-19 pandemic.
Keyphrases
- coronavirus disease
- polycystic ovary syndrome
- immune response
- sars cov
- respiratory syndrome coronavirus
- insulin resistance
- pregnancy outcomes
- risk factors
- estrogen receptor
- breast cancer risk
- cervical cancer screening
- toll like receptor
- single cell
- risk assessment
- cardiovascular disease
- cell therapy
- mesenchymal stem cells
- electronic health record
- deep learning
- machine learning